Medikaloka Hermina PT (HEAL) — Cash Flow Reinvestment Rate
Medikaloka Hermina PT (HEAL) has a Cash Flow Reinvestment Rate of 3.96x as of June 2025, reinvesting Rp893.33 Billion (capex Rp442.71 Billion plus investments Rp-450.61 Billion) from operating cash flow of Rp225.37 Billion. Check HEAL cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medikaloka Hermina PT Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Medikaloka Hermina PT across 10 annual periods. Explore Medikaloka Hermina PT (HEAL) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Medikaloka Hermina PT (2015–2024)
Year-by-year capital reinvestment analysis for Medikaloka Hermina PT. For live market cap and broader valuation context, see HEAL stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.08x | Rp4.65 Trillion | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +64.8% |
| 2023 | 2.48x | Rp3.27 Trillion | Rp1.32 Trillion | Rp1.59 Trillion | ▲ +10.5% |
| 2022 | 2.24x | Rp1.13 Trillion | Rp503.58 Billion | Rp1.13 Trillion | ▲ +211.9% |
| 2021 | 0.72x | Rp1.33 Trillion | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -19.9% |
| 2020 | 0.90x | Rp1.01 Trillion | Rp1.13 Trillion | Rp889.65 Billion | ▼ -26.3% |
| 2019 | 1.22x | Rp697.10 Billion | Rp572.58 Billion | Rp575.94 Billion | ▼ -66.8% |
| 2018 | 3.66x | Rp885.32 Billion | Rp241.67 Billion | Rp764.16 Billion | ▲ +18.0% |
| 2017 | 3.10x | Rp1.44 Trillion | Rp465.08 Billion | Rp696.31 Billion | ▲ +117.4% |
| 2016 | 1.43x | Rp517.92 Billion | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.4% |
| 2015 | 1.89x | Rp482.66 Billion | Rp255.71 Billion | Rp452.66 Billion | — |